DRUG · Unmapped registry intervention
DE-117 Ophthalmic Solution
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
NCT03691649
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Timolol Maleate Ophthalmic Solution 0.5%
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Glaucoma and Ocular Hypertensionunresolved
Interventions
Sponsors & collaborators
Santen Inc.lead sponsor
Mapped research locations
San AntonioTexas, United States3Las VegasNevada, United States3New YorkNew York, United States1Los AngelesCalifornia, United States1CincinnatiOhio, United States1ColumbusOhio, United States1PhoenixArizona, United States1JacksonvilleFlorida, United States1AustinTexas, United States1Salt Lake CityUtah, United States1CharlotteNorth Carolina, United States1MemphisTennessee, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03691649 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.